Article
Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients.
Acta oncologica (Stockholm, Sweden) - 1 Nov 2017
Schack Line M H, Petersen Stine E, Nielsen Steffen, Lundby Lilly, Høyer Morten, Bentzen Lise, Overgaard Jens, Andreassen Christian N, Alsner Jan
Abstract excerpt
INTRODUCTION: Normal tissue morbidity sets the dose limit for radiotherapy (RT) in cancer treatment and has importance for quality of life for cancer survivors. A previous study of prostate cancer patients treated with RT generated clinical data for radiation-induced morbidity measured by anorectal physiological methods and validated questionnaires. Other studies have identified genetic predictors associated with...
Topics
Join the communities discussing this publication.
